scispace - formally typeset
E

E. Aubrey Thompson

Researcher at Mayo Clinic

Publications -  108
Citations -  6131

E. Aubrey Thompson is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Breast cancer & Trastuzumab. The author has an hindex of 38, co-authored 91 publications receiving 5172 citations. Previous affiliations of E. Aubrey Thompson include Washington University in St. Louis.

Papers
More filters
Journal ArticleDOI

A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium

Zhenqiang Su, +164 more
- 01 Sep 2014 - 
TL;DR: The complete SEQC data sets, comprising >100 billion reads, provide unique resources for evaluating RNA-seq analyses for clinical and regulatory settings, and measurement performance depends on the platform and data analysis pipeline, and variation is large for transcript-level profiling.
Journal ArticleDOI

Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β-induced apoptosis

TL;DR: It is reported that the sensitivity to TGF-β-induced apoptosis is regulated by crosstalk between the Akt/PKB serine/threonine kinase and Smad3 through a mechanism that is independent of Akt kinase activity.
Journal ArticleDOI

MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing

TL;DR: The developed MAP-RSeq workflow is a comprehensive computational workflow that can be used for obtaining genomic features from transcriptomic sequencing data, for any genome, and has thus far enabled clinicians and researchers to understand the transcriptomic landscape of diseases for better diagnosis and treatment of patients.
Journal ArticleDOI

The PRKCI and SOX2 Oncogenes Are Coamplified and Cooperate to Activate Hedgehog Signaling in Lung Squamous Cell Carcinoma

TL;DR: In this paper, two oncogenes coamplified on chromosome 3q26, PRKCI and SOX2, cooperate to drive a stem-like phenotype in lung squamous cell carcinoma (LSCC).
Journal ArticleDOI

Atypical Protein Kinase Cι Plays a Critical Role in Human Lung Cancer Cell Growth and Tumorigenicity

TL;DR: The data demonstrate that PKCι is a critical lung cancer gene that activates a Rac1→Pak→Mek1, 2→Erk1,2 signaling pathway required for transformed growth, and indicate thatPKCι may be an attractive molecular target for mechanism-based therapies for treatment of lung cancer.